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 Abstract:  
There is increasing recognition of the co-occurrence of autism and schizophrenia spectrum 
disorders. However, the clinical significance of this on outcomes such as depression and 
suicidal thinking has not been explored. This study examines the association of autism 
spectrum traits, depressive symptoms and suicidal behaviour in individuals with psychotic 
experiences.  
In two cross sectional studies, individuals from a non-help seeking university student sample 
and patients with first episode psychosis (FEP) service completed standardised measures of 
autism spectrum traits, psychotic experiences, depressive symptoms and suicidal thinking.  
In healthy non-help seeking students, increased autism traits and increased subclinical 
psychotic experiences were significantly associated with depressive symptoms; a significant 
interaction effect suggests their combined presence has a greater impact on depression. In 
FEP, high autism traits and positive symptoms were associated with increased depression, 
hopelessness and suicidality, however there was no significant interaction effect. In FEP a 
multiple mediation model revealed that the relationship between autism traits and risk for 
suicidality was mediated through hopelessness.  
Young people with subclinical psychotic experiences and all patients with FEP should be 
screened for autism spectrum traits, which may have significant impact on clinical 
outcomes. Tailored interventions for patients with high levels of autistic spectrum co-
morbidities in FEP should be a priority for future research. 
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1. Introduction 
Despite early recognition of similarities between autism and schizophrenia at the times of 
Bleuler and Kanner, historically these have been understood as two distinct disorders 
(Kolvin, 1971). Time course (onset in early childhood vs adolescent) and progression (stable 
vs progressive) are two possible distinguishing features(Chisholm et al., 2015; Wood, 2017). 
However, it is now recognised that autism spectrum disorder and schizophrenia spectrum 
disorders share not only some clinical similarities, but also a biological, particularly genetic, 
liability (Ruzzo and Geschwind, 2016). Whilst autism has long been understood as occurring 
on a spectrum, with a continuum of severity and deficits identifiable from population to 
disorder level (Young et al., 2005), recently psychosis has also been suggested to exist on a 
continuum; positive symptoms are reported in the general population, can be used to 
identify those at heightened risk of developing psychosis with the ultra-high risk paradigm, 
and are seen in schizophrenia and other severe mental illnesses (Yung et al., 2006).  
At the population level, autistic and psychosis traits are evidentially co-occurring; using the 
Avon Longitudinal Birth Cohort, Sullivan et al demonstrated that poorer pragmatic language, 
a key deficit in autism spectrum disorders, was associated with later psychosis and 
depression (Sullivan et al., 2016). In the same cohort, Siebald and colleagues showed that 
children aged 8 diagnosed with pervasive developmental disorders, which included the 
DSM-IV classification of Autism (Association and DSM-IV., 1994), had heightened risk of later 
psychotic experiences with an odds ratio of 8 (Siebald et al., 2016).  
Within clinical populations, the two disorders co-occur at higher rates than would be 
expected by chance. There is a reported mean incidence of schizophrenia spectrum 
disorders of 13.8% in autism spectrum disorder populations, and a mean incidence of 
autism spectrum disorder of 24.1% in schizophrenia spectrum disorder populations 
(Chisholm et al., 2015). Shared clinical features of autism spectrum disorders and 
schizophrenia spectrum disorders also include difficulty with social communication, 
emotional expression, salience and restrictive behaviours (Abu-Akel et al., 2017a; Hommer 
and Swedo, 2015; Ruzzo and Geschwind, 2016). Depression is common in both autism 
spectrum disorder and schizophrenia spectrum disorders. It has been reported that 14-20% 
of young people with autism spectrum disorders have experienced a significant depressive 
episode by the age of 18 (Gotham et al., 2015). Likewise, up to 80% of patients with 
schizophrenia may experience significant depression (Upthegrove 2010), and this has 
significant long-term consequences for autism spectrum disorders and schizophrenia, 
including suicide. Lifetime prevalence of completed suicide in schizophrenia is between 7-
10% (Dutta et al., 2011; Häfner et al., 2005; Upthegrove et al., 2010), and the prevalence of 
suicidal behaviour in autism spectrum disorder is between 11 and 50% (Zahid S., 2017).  
We have previously shown that depression, positive symptoms and hopelessness are known 
precursors of self-harm and suicide in schizophrenia spectrum disorders (Upthegrove et al., 
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2014). However, the role of autism spectrum disorder traits as a potential pathway to 
depression and suicidality in schizophrenia spectrum disorders has not been explored to 
date.  
Whilst there has been a considerable amount of recent recognition of the co-occurrence of 
autism spectrum disorder and schizophrenia spectrum disorders, and how this might inform 
aetiological understanding, the evidence of the clinical significance of this co-occurrence has 
yet to develop. This knowledge is needed for evidence-based treatment and management 
decisions. This study aims to determine the importance, in terms of depression and suicidal 
behaviour, of autism traits in individuals within the spectrum of psychotic experiences. 
Given that both disorders are associated with depression and suicidal behaviour, we predict 
that depression and suicidal behaviour would be increasingly prevalent when autistic 
spectrum traits and psychosis co-occur.  
Hypotheses: 
1. Autism traits and subclinical psychotic experiences are associated with increased levels 
of depressive symptomatology in a healthy, non-help seeking population. 
2. Autism traits are associated with positive symptoms and their combined presence 
increases depression and hopelessness in people with first episode psychosis. 
3. Autism traits in people with first episode psychosis increase the risk of suicidality over 
and above other known risk factors. 
 
 
2. Materials and Method: 
2.1 Sample 1: Healthy, non-help seeking  
Data were collected from 381 University students. Participants were recruited through the 
University of Birmingham Research Participation Scheme for a course credit or small 
honorarium. Participants self-reported that they had no history of psychiatric illness, 
epilepsy, neurological disorders or brain injury (including self-report of any formal diagnosis 
of ASD, epilepsy, traumatic brain injury, and/or other known neurological or 
neurodevelopmental condition), and no current or past alcohol and/or substance abuse 
problems. The University of Birmingham Research Ethics Committee approved the study, 
and written informed consent was obtained from all participants. 
Participants completed the CAPEp (Community Assessment of Psychotic Experiences: 
positive psychotic-like experiences), which is a 20-item positive scale questionnaire (Stefanis 
et al., 2002). The assessment of positive psychotic-like experiences was assessed with the 
CAPEp rather than the full Community Assessment of Psychotic Experiences (CAPE) as 
previous literature suggests that negative psychotic experiences maybe cofounded by the 
presence of autistic traits/autism spectrum disorders (Spek and Wouters, 2010). 
4 
 
Participants also completed the AQ (The Autism-Spectrum Quotient) (Baron-Cohen et al., 
2001), a 50-item questionnaire which examines 5 domains along the autism spectrum: social 
skills; attention switching; attention to detail; communication; and imagination. Whist the 
AQ is not a diagnostic instrument, it is a well-validated self-report measure with a 
Cronbach’s Alpha of 0.81 (Hurst et al., 2007). A score of more than 32 is regarded as 
indicative of autism spectrum disorder and people with autism spectrum disorder rarely 
score below 26 (Baron-Cohen et al., 2001)  
Finally, participants completed the CESD-R (The Center for Epidemiologic Studies Depression 
Scale-Revised) to assess the presence of depressive symptomatology (Van Dam and 
Earleywine, 2011). 
2.2 Sample 2: First Episode Psychosis  
Ninety-nine participants with treated first episode psychosis were recruited from 
Birmingham Early Intervention Services, a community based clinical program with 
responsibility for the assessment and treatment of patients with first episode psychosis. 
Birmingham Early Intervention Services see approximately 200 new patients each year, 
referred from primary and secondary care services. Patients within the service receive 
antipsychotic medication, care-coordination and psychological interventions as needed.  
Ethical approval was given by UK National Research Ethical Committee (NRES), Reference 
Number 13/WM/0213. Inclusion criteria included age of 16-35 years with a diagnosis of first 
episode of psychosis in keeping with ICD-10 F20-23, F25-29, F30.2, F31, F32.3. Exclusion 
criteria included a lack of capacity to consent, unable to communicate verbally in English, 
and known neurological disorder (including but not limited to epilepsy, traumatic brain 
injury and learning disability). Patients meeting inclusion and exclusion criteria were 
approached by their clinical team, and no parameters were set for length of treatment. 
Participants completed; SBQ-R (The Suicide Behaviours Questionnaire-Revised) (Osman et 
al., 2001) which consists of 4 questions that assess different aspects of suicidality. It 
examines lifetime suicidal ideation and suicide attempt, the frequency of suicidal ideation 
over the last year, the threat of suicide attempt, and the likelihood of attempting suicide in 
the future (Osman et al., 2001); AQ (The Autism-Spectrum Quotient) (Baron-Cohen et al., 
2001); PANSS (Positive and Negative Syndrome Scale) (Kay et al., 1987), to capture current 
severity of symptoms on the basis of the standard semi-structured interview. Positive 
symptoms were assessed by PANSS positive (PANSS-P) subtotal. Depression was rated using 
PANSS items G1-3 and G6 (PANSS-D), which has been shown to have validity and good 
correlation with other depression measures used in psychosis (Lako et al., 2012); BHS (Beck 
Hopelessness Scale) (Beck and Steer, 1988), a 20-item tool designed to measure three major 
aspects of hopelessness; feelings about the future, loss of motivation, and expectations. 
 
 
5 
 
2.3 Statistical Analysis 
Inspection of the data suggests that the distribution of all scores in both the healthy and 
clinical samples were within the accepted range, of -/+ 2 skewness, for parametric analyses 
(Gravetter and Wallnau, 2014)  
2.3.1 Sample 1:    
The association of the participants’ standardised AQ and CAPEp scores and their interaction 
with the CESD-R scores was examined in a linear regression model using Generalized Linear 
Models (GLMs), controlling for age and gender. Interactions were probed using the 
MODPROBE method for SPSS where the effect of one predictor on the outcome measure 
examined at the mean, 1 s.d. below the mean and 1 s.d. above the mean of the other 
predictor. This procedure does not involve splitting the sample into smaller groups using 
these cut-off points, rather it estimates the effect of a predictor on the dependent variable, 
while holding constant the other predictor at a discrete point (Hayes and Matthes, 2009). 
Accordingly, this approach allows us to infer from the model the effect of autism traits and 
positive psychotic-like experiences on depression, in a population with certain composition 
of positive psychotic-like experiences and autism traits. 
        2.3.2  Sample 2: First Episode Psychosis  
In three separate GLMs, linear regression models examined the association of AQ and 
PANSS-P, and their interaction, with the participants’ scores on the PANSS-D, BHS and SBQ-
R, while controlling for age and gender. However, collinearity diagnostics showed high 
multicollinearity in all the models for AQ (Variance Inflation Factor (VIF) =5.91—7.76); 
PANSS-P (VIF =9.84—16.39); and the interaction term (VIF =19.68—31.30). We addressed 
the collinearity problem by applying the regression residual method based on the Gram-
Schmidt orthogonalization procedure described in (Draper and Smith, 2014)). A complete 
orthogonalization (i.e., removal of common variance) of all predictors was accomplished as 
follows: 
Step 1. AQ and PANSSp were orthogonalized by partialling out AQ from PANSS-P.   
Step 2.  The interaction term (AQ x PANSS-P) was orthogonalized by partialling out both AQ 
and PANSS-P.  
This procedure rendered 3 uncorrelated variables: AQ, PANSS-P residual, and AQ x PANSS-P 
residual. The standardized values of these orthogonalized predictors were used in the 
subsequent GLMs.  
Additionally, to examine whether the effect of AQ on suicidality was mediated by positive 
symptoms, hopelessness, and/or depression, a multiple mediation analysis was conducted 
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using SPSS Macro for Multiple Mediation (Preacher and Hayes, 2008). This analysis was 
conducted with 5000 bootstrap resamples, while controlling for age and gender. 
 
3. Results: 
3.1 Sample 1: Healthy non help-seeking: The sample was 21% male (male/female=80/301); 
Age range 17-39; mean age (SD) = 20.61 (3). Mean AQ score was 15.32 (6.04). Two 
participants (0.52%) had a score indicative of likely autism spectrum disorder (as defined by 
AQ>32)(Baron-Cohen et al., 2001), and 19 (4.99%) when using the more lenient indicative 
score of AQ>26 (Woodbury-Smith et al., 2005). Mean CAPEp and CESD-R scores were 26.55 
(4.24) and 12.56 (10.81), respectively. See table 1. 
3.2 Sample 2: First Episode Psychosis: The FEP sample was 67.7% male 
(male/female=67/32); Age range 16-36, mean age (SD) = 25.61 (5.0). Mean AQ score was 
20.76 (7.96). Twenty-five participants (25%) scored >26 or above on the AQ, of which 8 
participants (9.2%) scored over 32. One per cent of participants had a lifetime history of 
suicide plans (with or without attempt), and 24% a lifetime history of suicide attempt.  
 
***Table 1 about here *** 
 
3.3 Hypotheses 1: Autism traits and psychosis are associated with increased incidence of 
depression in a healthy, non-help seeking population 
The GLM regression model yielded an overall significant model (Waldχ2=92.23, df=5; 
p<0.001; R2=0.216). As can be seen from Table 2, the analysis revealed a significant positive 
association between CESD-R and the interaction term of AQ x CAPEp. 15.6% of the total 
variance explained by the model was accounted for by the interaction term (R2 change 
=0.034, F=16.03; p<0.001).  
 
***Table 2 about here*** 
 
The analysis presented in Figure 1 probes the interaction between AQ and CAPEp. Figure 1A 
shows that while AQ had no effect on CESD-R at 1SD below the mean of CAPEp (β (SE) = 0.03 
(.73), t = 0.043, p = 0.97), it was significantly associated with higher CESD-R scores at the 
mean (β (SE) = 2.11 (0.53), t = 4.01, p < 0.001) and 1SD above the mean (β (SE) = 4.20 (0.76), 
t = 5.54, p < 0.001) of CAPEp. Conversely, in Figure 1B, the association between CAPEp and 
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CESD-R was not significant at 1SD below the mean (β (SE) = 0.50 (0.87), t = 0.57, p = 0.57) of 
AQ, but positively significant at the mean (β (SE) = 2.58 (0.55), t = 4.66, p < 0.001) and at 1SD 
above the mean (β (SE) = 4.66 (0.63), t = 7.40, p < 0.001) of AQ. See also supplementary 
Figure 1. 
 
***figure 1 about here*** 
 
 
3.4 Hypotheses 2: Autism traits are associated with positive symptoms and their combined 
presence increases depression and hopelessness in FEP. 
There was a significant correlation between PANSS-P and AQ total scores (r= 0.42, p<0.001).  
3.4.1 Depression:  
The GLM results yielded an overall significant model (Waldχ2=30.86, df=5; p<0.001; 
R2=0.300). As can be seen from Table 3, there was a significant positive association between 
PANSS-D scores and both AQ and PANSS-P scores. The interaction term of AQ x PANSS-P 
was non-significant.  
      3.4.2 Hopelessness:  
The GLM results yielded an overall significant model (Waldχ2=28.92, df=5; p<.001; R2=.323). 
As can be seen from Table 3, there was a significant positive association between BHS total 
scores and both AQ and PANSS-P scores. The interaction term of AQ x PANSS-P was non-
significant.  
 
***table 3 about here*** 
 
3.5 Hypotheses 3: Autism traits in first episode psychosis increase risk of suicidality over and 
above other known risk factors  
The GLM results yielded an overall significant model (Waldχ2=16.47, df=5; p=.006; R2=.200). 
As can be seen from Table 3, there was a significant positive association between SBQ-R 
total scores and both AQ and PANSS-P scores. There was also a significant association 
between gender and SBQ-R, such that males (M(se)=2.61(0.10)) reported significantly lower 
SBQ-R scores compared to the females (M(se)=2.94(0.12)). The interaction term of AQ x 
PANSS-P was non-significant.  
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Multiple mediation model:  The overall multiple mediation model was significant (F (6,65)= 
7.22, p<0.001, R2 = 0.40). There was a significant indirect effect of AQ through the mediator 
hopelessness on SBQ-R (ab = 0.117, bias-corrected 95%CI = 0.05 – 0.22), accounting for 71% 
of the total effect of AQ on SBQ-R (c path = 0.164(0.057), t=2.88, p=.005). The indirect 
effects of PANSS-D (ab = 0.057, bias-corrected 95% CI= -0.007 – 0.139) and PANSS-P (ab = 
0.019, bias-corrected 95%CI = -0.043 – 0.095) were non-significant (see Figure 2). 
***figure 2 about here*** 
 
4. Discussion: 
The aim of this study was to determine the importance of autism traits in individuals within 
the spectrum of psychotic experiences in the presence of depression and suicidal behaviour. 
The data presented from the FEP sample demonstrated that the prevalence of autistic 
spectrum traits is high, with 25% of the sample having AQ score indicative of need for 
formal diagnostic assessment and in keeping with the majority of studies reporting this co-
occurrence (Chisholm et al., 2015). Our novel findings are that this co-occurrence is clinically 
important; autism traits and positive symptoms were associated with a significantly 
increased level of depressive symptoms, hopelessness and suicidal thinking. Within the non-
help seeking population, autism traits and psychosis traits were associated with likewise 
higher levels of depressive symptomatology, such that their combined effect was greatest 
when both autism and psychosis traits are high. These findings suggest that autism traits are 
associated with increased depressive symptoms across the psychosis spectrum.  
Our findings are in keeping with the multiple aetiology and increased vulnerability models of 
autism spectrum disorder and psychosis co-occurrence (Chisholm et al., 2015). Although it is 
speculative to draw firm conclusions from our cross-sectional studies, with a high 
proportion of females in our university educated, healthy non-help seeking sample, it is 
possible that there is an increased vulnerability for both traits through a shared genetic 
liability (Carroll and Owen, 2009). It is also possible that the perception of genetic liability 
for both disorders leads to further stigmatizing attitudes, and subsequent depressive 
symptoms (Serafini et al., 2011). It is likewise speculative to draw inference on a direction of 
causality in the vulnerability to mood disorders and suicide autism spectrum traits and 
psychosis may bring. However, as autism traits are suggestive of long-term deficits, it is 
possible that these deficits lead to an increase to both psychotic-like symptoms and 
depression. Recent evidence suggests that anomalous experiences such as hallucinations 
are common and associated with significant distress in adults with autism spectrum disorder 
(Milne et al., 2017). The precipitation of psychotic symptoms may be via a reciprocal 
pathway of stress vulnerability and depression (Myin-Germeys and van Os, 2007), and 
autism spectrum disorder traits add to this vulnerability.  Freeman et al argue that emotion 
deregulation is responsible for the generation of clinically significant positive symptoms in 
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patients who cannot manage their emotional distress (Freeman et al., 2001). Thus, we may 
see higher rates of emotional dysregulation in patients with psychosis and high autism traits 
through this route. This is in keeping with an ‘autistic pathway’ to psychosis, mediated by 
emotional deregulations as Toal et al propose (Toal et al., 2009).  
Craddock and Owen describe a continuum model of psychosis and autism spectrum disorder 
traits with developmental disorders and autism traits at one end, through to schizophrenia, 
schizoaffective disorder and bipolar disorder with increasing frequency of affective 
symptoms at the other end (Craddock and Owen, 2010). Our results would challenge this 
model as the combined presence of autism traits and positive symptoms gives an increase 
association with depression with complex interaction. Our results would not support a 
diametric model of autism spectrum disorders and psychosis, which would predict that the 
combined presence of both would result in lesser impact. However, it is possible that their 
diametric effects are specific to the cognitive, but not an affective domain (Abu-Akel et al., 
2017a). This is consistent with a recent study of college students showing that the co-
occurrence of autism and schizotypal traits was associated with better social and executive 
function but poorer emotional expression (Shi et al., 2017). 
We reported that an interactive effect of autism traits and positive symptoms on depression 
was not seen in first episode psychosis, rather both had independent effects. Autism traits 
appear to increase risk of suicidal behaviour through increased hopelessness in first episode 
psychosis, even after controlling for the influence of age and gender. Once a level of illness 
severity reaches diagnostic significance in the psychosis spectrum, the role of other 
mediators such as stigma, shame, and powerlessness influence hopelessness and suicidal 
thinking (Upthegrove et al., 2014). Results from the present study also suggest a role for 
autism spectrum disorder traits. Matsuo (Matsuo et al., 2015) demonstrated that nearly 
50% of patients with schizophrenia had autism traits at levels typical for sub-threshold or 
threshold autism spectrum disorder, and that there was no difference between remitted or 
unremitted subjects. Thus, the indication, when combined with our novel findings, is that 
autism spectrum disorder traits can be identified at any stage or state of psychosis, and are 
likely to increase mood symptoms, hopelessness and suicidality.  
Dutta and Reininghaus show the risk for suicide within psychosis lasts for 15 or more years 
after diagnosis (Dutta et al., 2011; Reininghaus et al., 2015). Our findings of the role of 
autism spectrum disorder traits in depressive symptoms and suicidality are both novel and 
significant; it is possible that autism spectrum disorder traits contribute to a longer-term 
risk. It is speculative to consider how autism spectrum disorder traits might influence 
suicidal thinking in psychosis; it is possible they add to the isolation and social impact seen 
in early psychosis. Emotional impairment, anhedonia, alexithymia (the inability to identify 
one’s feelings), social isolation and social withdrawal are common experiences in both 
autism and psychosis (Larson et al., 2016). The combined presence of psychosis and autism 
traits may contribute to impairment in emotional communication, leading to such factors 
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that increase risk of depression and hopelessness such as isolation. Eack and colleagues 
demonstrate clear difficulties in facial emotional perception in autism, and Mehta et al show 
difficulties in social interaction in schizophrenia (Eack et al., 2014; Mehta et al., 2014); when 
these are present, this may lead to further social isolation. Within populations with 
psychosis, it has also been suggested that autism traits may also bring an additional impact 
on theory of mind deficits (Pickup and Frith, 2001), resulting in further social isolation. Some 
evidence suggests that this is specific to affective rather than cognitive theory of mind 
(Shamay-Tsoory and Aharon-Peretz, 2007). 
In this paper, we have assessed two samples across the spectrum of psychosis experiences; 
a healthy non-help seeking population and full first episode psychosis. Relatively large 
sample sizes allowed for regression analyses using linear models while controlling for age 
and gender. However, the study does have limitations that need to be acknowledged. Our 
non-help seeking sample was drawn from university students, with a high proportion of 
female participants and thus is not readily generalizable to the population as a whole, and is 
likely to be significantly higher in educational attainment than a general population. We 
used a self-report for health status in this group and a structured neurodevelopmental 
history has not been taken. Within the FEP sample, depressive symptomatology was 
measured by PANSS-D and not a more specific scale for the assessment of depression in 
schizophrenia, and thus may have been influenced by the presence of participants with 
significant negative symptoms. PANNS- Positive symptoms were strongly correlated with AQ 
score, and although there was not an interaction effect, suggesting independent effects, it is 
possible some autistic features measured were secondary to positive symptoms 
or disorganization. Suicidal behavior was recorded from self-report, and whilst the SBQ-R 
contains a measure that of past lifetime history of suicidal behavior, we were not able to 
control for past suicide attempts which will have been variously proximal to our assessment 
time. A further limitation is the self-report AQ rather than diagnostic interview in both 
samples, which further leads to the exploratory nature of our results. However the AQ has 
previously been used to assess traits with validity and in clinical populations (Milne et al., 
2017). At present, there is not a valid diagnostic measure for autism in schizophrenia, and 
this is clearly an area of future research need. As a cross-sectional study, with autism traits 
measured by self-report, limited speculation is possible in direction of influence.  
 
Conclusion: 
Our results suggest that when autism spectrum traits and psychotic symptoms co-occur, 
there are significant implications for depressive psychopathology and suicidal behaviour. 
Clinical services for psychosis should be vigilant in detecting autism traits, as this may give 
additional information for prediction of depression, hopelessness and risk of suicide. The 
interventions routinely offered for first episode psychosis, including Cognitive Behavioural 
Therapy for psychosis and Behavioural Family Therapy, may also need to be tailored for 
patients with significant autism spectrum disorder traits, to ensure they are accessible and 
effective. As this group is at heightened risk for depression, hopelessness and suicide, these 
interventions are indeed needed.  
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Table 1. Clinical descriptors of Sample 1 and 2 
Sample 1 Minimum Maximum Mean (s.d.)  
Age  17 39 20.61 (3) 
AQ 3 35 15.3 (6.0) 
CAPEp 20 40 26.55 (4.24) 
CESD-R 0 73 12.56 (10.81) 
    
Sample 2 Minimum Maximum Mean (s.d.)  
Age 16 36 25.61 (5) 
AQ Total Score 5.00 42.00 20.76 (7.96) 
PANSS Negative 7.00 31.00 12.36 (5.29) 
PANSS Positive 7.00 30.00 12.34 (5.65) 
PANSS-D  4 22.00 8.54 (4.31) 
BHS Total 0 20.00 6.36 (5.43) 
SBQ-R Total 3.00 17.00 7.45 (4.07) 
 
Table 2. Summary of regression coefficients with total CESD-R scores as the dependent 
variable in healthy, non-help seeking sample  
 
β SE (95% C.I.) Waldχ2 p 
Age -0.481 0.152 (-0.778, -0.183) 10.04 0.002 
Gender = Male -0.272 1.238 (-2.698, 2.154) .05 0.83 
AQ 2.118 0.523 (1.093, 3.142) 16.40 <0.001 
CAPEp 2.585 0.548 (1.511, 3.659) 22.24 <0.001 
AQ x CAPEp 2.081 0.516 (1.071, 3.091) 16.30 <0.001 
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Table 3. Summary of regression coefficients of three models with total PANSS-D score, BHS 
total and SBQ-R as dependent variables in first-episode psychosis sample 
 
Depression (PANSS-D) β SE (95% C.I.) Waldχ2 p 
Age 0.019 0.013 (-0.006, 0.044) 2.19 0.139 
Gender = Male -0.109 0.141 (-0.386, 0.167) 0.60 0.44 
AQ 0.305 0.068 (0.171, 0. 438) 20.05 <0.001 
PANSS-Positive 0.238 0.059 (0.121, 0.354) 16.07 <0.001 
AQ x PANSS-Positive -0.047 0.060 (-0.165, 0.071) 0.61 0.44 
Hopelessness (BHS Total) 
Age 0.013 0.021 (-0.029, 0.054) 0.34 0.56 
Gender = Male -0.054 0.236 (-0.517, 0.408) 0.05 0.82 
AQ 0.616 0.120 (0.380, 0.851) 26.28 <0.001 
PANSS-Positive 0.193 0.098 (0.001, 0.385) 3.88 0.049 
AQ x PANSS-Positive -0.082 0.142 (-0.361 , 0.197) .33 0.57 
Suicidality (SBQ-R) 
Age -0.003 0.015 (-0.032, 0.027) 0.03 0.87 
Gender = Male -0.321 0.156 (-0.626, -0.016) 4.23 0.039 
AQ 0.235 0.079 (0.082, 0.389) 8.99 0.003 
PANSS-Positive 0.190 0.076 (0.041, 0.339) 6.21 0.013 
AQ  x PANSS-Positive 0.017  0.103 (-0.184, 0.219) 0.03 0.87 
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 Fig. 1. The interactive effect of autism traits and positive psychotic-like experiences on 
depressive symptoms. 
  
(A) Visualizes the association between autism traits and depressive symptoms by plots of 
simple regression lines with low (−1 SD), average, and high (+1 SD) CAPEp scores as 
moderators, showing an increase in the positive effect of autism traits in individuals scoring 
average and above on CAPEp. (B) Visualizes the association between subclinical psychotic 
experiences and depressive symptoms by plots of simple regression lines with low (−1 SD), 
average, and high AQ (+1 SD), showing a positive effect of positive subclinical psychotic 
experiences in individuals scoring average and above on AQ.  
*** = p-value <.001. AQ=Autism Quotient; CAPEp= Community Assessment of Psychic 
Experiences, positive subscale; CESD-R= The Center for Epidemiologic Studies Depression 
Scale-Revised (Fig. 1S. depicts the raw data of the model presented in Fig. 1A and 1B). 
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Fig. 2. Multiple mediation model testing the effect of autism traits on suicidality through the 
mediators: hopelessness, PANSS positive and PANSS depressive symptoms.  
 
 
 
 
 
 
 
 
ab= coefficients of the 5000 bootstrap resamples indirect effects of AQ on SBQ-R through 
the proposed mediators, while controlling for age and gender. c represents the coefficient 
of the direct effect of AQ on SBQ-R; AQ= Autism Quotient; PANSS= Positive and Negative 
Syndrome Scale; SBQ-R= The Suicide Behaviours questionnaire-revised; * = p<.05; **p<.01; 
***p<.001; ✜p=.078. 
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Figure 1S: 3-D representation of the relationship of autism traits (AQ) and positive 
psychotic- 
like experiences (CAPEp) (represented as standardized Z scores) with depressive 
symptomatology  
(CESD-R). The negative scores represent low tendencies and the positive scores represent 
high tendencies. 
 
19 
 
